Relugolix-estradiol-norethisterone (also known as relugolix combination therapy or Ryeqo), is the “first of its kind” daily ...

A new treatment for a common painful condition and two other drugs will be made cheaper to improve access to treatment for ...

Endometriosis affects millions of people - and this new breakthrough treatment could be a game-changer for some ...

Ryeqo drug is hailed as a ‘potential step-change’ in how endometriosis is treated A new pill designed to transform the ...

This announcement is all about making treatment cheaper and easier, so women can focus on getting the care they need.” ...

Gedeon Richter's drug is the only licensed GnRH antagonist option and, unlike GnRH agonists like Takeda's Prostap ...

A new combination pill, relugolix–estradiol–norethisterone, has been approved for treating endometriosis on the NHS. This marks the first long-term, daily oral treatment for the condition, offering a ...

The National Health Service (NHS) in England has approved Gedeon Richter’s Ryeqo (relugolix + estradiol + norethisterone), ...

Ryeqo is likely to start being prescribed to patients in Wales within two months, but there will be restrictions on who can ...

A new treatment for a common painful condition and two other drugs will be made cheaper to improve thousands of Australian ...

The Albanese government will make treatments for IVF and endometriosis cheaper as the government rolls out further ...

The contraceptive pill Slinda, endometriosis treatment Ryego and an IVF drug will be made cheaper via the Pharmaceutical Benefits Scheme, the Albanese government will announce.